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ABSTRACT. Objective: Cannabis is the most widely used illicit drug 
in the United States, and as a result, it is associated with signifi cant 
public health costs. The present study sought to investigate whether item 
response theory (IRT) methods could be used to identify meaningful dif-
ferences in how cannabis abuse and dependence symptoms (determined 
by criteria from the Diagnostic and Statistical Manual of Mental Disor-
ders, Fourth Edition) function as indices of the severity of misuse across 
two ethnic groups: Native Americans and European Americans. Method: 
Participants were drawn from two previously collected samples, a 
population of Native Americans living on contiguous reservations (n = 
406) and the University of California at San Francisco Family Alcohol-
ism Study (n = 728). Cannabis use disorder symptoms were assessed 
using the Semi-Structured Assessment for the Genetics of Alcoholism. 
Results: Exploratory factor analysis demonstrated that the cannabis 
abuse and dependence symptoms indexed a single latent trait measuring 
severity of cannabis use. IRT and multiple indicators multiple causes 
(MIMIC) analyses suggested meaningful differences in the functioning 
of these symptoms across ethnic groups. Withdrawal represented a more 
prevalent and less severe symptom among Native Americans relative to 
European Americans, whereas each of the cannabis abuse symptoms and 
a symptom assessing psychological and health problems resulting from 
cannabis use were less prevalent but more severe in Native Americans. 
Conclusions: The fi ndings suggest differences in how cannabis use dis-
orders manifest in these populations and thus have implications for the 
assessment of these disorders as well as theories attempting to explain 
the increased rates of substance use diagnoses more generally among 
Native Americans living on reservations. (J. Stud. Alcohol Drugs, 74, 
320–328, 2013)
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CANNABIS IS THE MOST WIDELY USED illicit drug in the United States, with survey data indicating that 
more than 17 million individuals used cannabis in 2010 
(Substance Abuse and Mental Health Services Administra-
tion, 2011), and lifetime rates of cannabis dependence are 
estimated to range from 1.3% to 4.2% (American Psychiatric 
Association, 1994; Anthony et al., 1994; Compton et al., 
2004). Cannabis use is associated with psychiatric problems, 
including a pattern of apathy, loss of goal-directed behavior, 
and cognitive impairment referred to as the “amotivational 
syndrome” (Pope et al., 2001; Schuckit, 2006; Sharma, 
1975; Solowij et al., 2002) as well as psychotic illness and 
depression (Degenhardt et al., 2003; Hall et al., 2004). No-
tably, early cannabis use is also associated with progression 
to other illicit drug use (the “gateway” drug hypothesis) 
(Fergusson and Horwood, 2000; Lynskey et al., 2003).
 Previous studies have suggested that cannabis use among 
Native Americans living on reservations is particularly high, 
with prevalence rates of cannabis use disorders estimated to 
be two to three times higher than those observed in White 
samples (Beauvais, 1992; Plunkett and Mitchell, 2000). To 
explain this increased prevalence, researchers have proposed 
that social and economic conditions on reservations often 
lead to a disconnect between sobriety and access to employ-
ment, education, and housing (Spillane and Smith, 2007). If 
supported, this would suggest that the psychosocial conse-
quences of heavy cannabis use may differ between Native 
Americans living on reservations and other ethnic groups. 
Potential cultural differences such as these are of particular 
interest, given efforts to explore cultural differences in the 
manifestation of psychopathological symptoms as evidenced 
by the formation of the Gender and Cross-Cultural Issues 
Study Group for the development of the Diagnostic and Sta-
tistical Manual of Mental Disorders, Fifth Edition (DSM-5).
 The application of analytic methods based on item re-
sponse theory (IRT) to the study of substance use disorders 
has been particularly useful in exploring potential differences 
in symptom functioning across a number of social and ethnic 
groups. Briefl y, IRT models assume that individual items or 
symptoms assess a continuous latent trait and estimate where 
on the latent trait dimension an item has a 50% probability 
of endorsement (Embretson and Reise, 2000). This provides 
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a measure of item diffi culty that is related to the rate of 
endorsement of the item, because low-frequency items will 
be considered more diffi cult. Further, how precisely the 
item can be located on the latent trait provides an index of 
item discrimination. When applied to psychiatric disorders, 
IRT analysis uses the diagnostic criteria as items and can be 
used to assess the severity of individual symptoms (Martin 
et al., 2006). Additionally, group differences in item severity, 
referred to as differential item functioning (DIF), can be as-
sessed across stratifying variables of interest, such as gender 
or ethnic group.
 In recent years, IRT methods have been used to dem-
onstrate that substance abuse and dependence symp-
toms—rather than indexing distinct, hierarchically ordered 
disorders—measure a single construct and that the relative 
severities of individual symptoms of each disorder fail to 
conform to the abuse–dependence hierarchy (Helzer et al., 
2007). These fi ndings have proven extremely robust and have 
led the DSM-5 committee to combine these disorders into 
a single syndrome with severity measured by the number of 
symptoms endorsed (O’Brien, 2011).
 In addition to examining the relative severity of substance 
abuse and dependence symptoms in the general population, 
IRT methods have been used to explore differences in how 
symptoms function between distinct subpopulations. For ex-
ample, several studies have reported evidence of DIF across 
gender for alcohol (Harford et al., 2009) and cannabis use 
disorder symptoms (Agrawal and Lynskey, 2007; Martin et 
al., 2006; Srisurapanont et al., 2012), although there have 
been some exceptions (Compton et al., 2009; Piontek et 
al., 2011; Saha et al., 2006). In contrast, although rates of 
substance use disorders (Grant et al., 2004) including can-
nabis use disorders (Stinson et al., 2006) vary between eth-
nic groups, few studies have used IRT to examine potential 
differences in the severity of substance misuse symptoms in 
individuals of different ethnic backgrounds. A few studies 
have identifi ed such differences across ethnic groups for 
alcohol use disorder symptoms (Harford et al., 2009; Saha 
et al., 2006; Wu et al., 2009), but, to our knowledge, no 
studies have examined differences in cannabis abuse and 
dependence symptom functioning across ethnic groups.
 As part of a larger study examining the etiology of sub-
stance use disorders in a community sample of American 
Indians living on reservations (see Ehlers et al., 2001, 2004, 
2007; Gilder et al., 2004, 2009), the present study applied 
IRT methods to accomplish two specifi c aims: (a) to evalu-
ate whether cannabis misuse symptoms assess a continuous 
latent trait that indexes the severity of cannabis use in both 
Native Americans living on reservations and European 
Americans and (b) to evaluate whether individual cannabis 
misuse symptoms differentially index severity in these two 
populations. Because the Native American community under 
study has been shown to exhibit very high rates of substance 
use disorders (e.g., 70% alcohol dependent, 60% cannabis 
dependent), we chose to use an equally affected population 
of European Americans for the present report, the University 
of California, San Francisco (UCSF) Family Alcoholism 
Study population (70% alcohol dependent, 44% cannabis 
dependent), which is a nationwide population-based sample 




 Data for the present study were collected at two indepen-
dent sites, the UCSF and The Scripps Research Institute (La 
Jolla, CA), and assessment procedures at each institution 
were approved by their respective institutional review boards. 
Participants at both sites were fully briefed on the nature 
of the study and provided written informed consent before 
study enrollment. Ongoing management and analysis of 
study data collected at the UCSF site were approved by the 
institutional review board at the University of North Caro-
lina at Chapel Hill. Data collection at The Scripps Research 
Institute was also approved by the Indian Health Council, a 
tribal review group overseeing health issues for the reserva-
tions where recruitments took place.
 UCSF Family Alcoholism Study sample. Participants 
in the present study represent a subset of the UCSF Fam-
ily Alcoholism Study who reported European ancestry and 
prior exposure to cannabis as defi ned by smoking marijuana 
at least 21 times in a single year. This criterion was derived 
by the authors of the Semi-Structured Assessment for the 
Genetics of Alcoholism (SSAGA) to screen for cannabis use 
among interviewees and was included in the present study 
to ensure that participants in both study samples had similar 
degrees of cannabis exposure. The UCSF Family Alcoholism 
Study sample was recruited nationwide for inclusion in a 
study of the genetics of alcoholism and other substance de-
pendence. Responding individuals were invited to participate 
if they met the screening criteria for alcohol dependence at 
some point in their lifetime and had at least one sibling or 
both parents available to participate. Permission was then 
obtained from the proband to invite relatives to participate 
by mail. Probands with serious drug dependencies other than 
cannabis (e.g., for stimulants, cocaine, or opiates) and those 
who reported any history of intravenous substance use were 
excluded. Also excluded were subjects reporting a current or 
past diagnosis involving psychotic symptoms (e.g., schizo-
phrenia and bipolar disorder with psychotic symptoms), 
a life-threatening illness, or an inability to speak and read 
English. Of the 2,524 total participants in the UCSF Family 
Alcoholism Study, 728 reported prior cannabis exposure 
and were included in the present report. Participants were 
56% female (n = 410), were an average age of 42.1 years 
(SD = 9.4), possessed an average of 14.3 (SD = 2.7) years of 
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education, included 70% who met the criteria for DSM-IV 
(American Psychiatric Association, 1994) alcohol depen-
dence, and included 44% who met the criteria for DSM-IV 
cannabis dependence.
 Native American sample. Participants from this Native 
American sample were recruited from eight geographically 
contiguous reservations with a total population of about 
3,000 individuals. Briefl y, individuals reporting at least 
1/16th Native American heritage who were between ages 18 
and 82 years were recruited to participate using a combina-
tion of a venue-based method for sampling hard-to-reach 
populations (Kalton and Anderson, 1986; Muhib et al., 2001) 
and a respondent-driven procedure (Heckathorn, 1997), as 
reported previously (Ehlers et al., 2004). Participants were 
included in the present study if they reported prior exposure 
to cannabis as defi ned by smoking marijuana at least 21 
times in a single year during their lifetime. Of the 775 total 
participants in the Native American sample, 406 reported 
prior cannabis exposure and were included in the present 
report. Participants were 49% female (n = 199), were an 
average age of 29.31 years (SD = 10.84), possessed an aver-
age of 11.42 (SD = 1.50) years of education, included 70% 
who met the criteria for DSM-IV alcohol dependence, and 
included 60% who met the criteria for DSM-IV cannabis 
dependence.
Measures
 Lifetime symptoms of DSM-IV diagnoses of cannabis 
abuse and dependence were obtained using a modifi ed ver-
sion of the SSAGA (Bucholz et al., 1994). In this modifi ed 
version, legal problems resulting from cannabis use were not 
assessed. Additionally, minor differences in the versions of 
the SSAGA administered to the UCSF Family Alcoholism 
Study and Native American samples led to the alteration of 
the “continued use despite physical or psychological prob-
lems” symptom. Data were collected at both sites regarding 
whether participants experienced physical or psychological 
problems as a result of their cannabis use, but data were 
not collected from all UCSF sample participants regarding 
whether they continued to use cannabis despite experiencing 
these problems. Thus, assessment of this symptom from both 
samples was modifi ed to refl ect if participants experienced 
these problems regardless of whether they continued to use 
cannabis.
Data analysis
 Preliminary analyses were conducted to assess the 
prevalence of the assessed DSM-IV cannabis abuse and 
dependence symptoms using SPSS Version 19 (SPSS Inc., 
Chicago, IL). Differences in prevalence rates between sam-
ples were assessed using a 2 × 2 contingency analysis and 
a Fisher’s exact test to determine signifi cance (see Table 1 
for results). All subsequent analyses were conducted with 
MPlus Version 6 using the maximum likelihood estimator 
that is robust to nonnormality of the observed variables 
(MLR) (Muthén and Muthén, 2010).
 To evaluate the unidimensionality of the cannabis symp-
toms, which is required for an IRT analysis, we conducted 
an exploratory factor analysis (EFA) of the three abuse and 
seven dependence symptoms assessed and then conducted a 
confi rmatory factor analysis (CFA) to evaluate model fi t us-
ing the sample size–adjusted Bayesian information criterion 
(SABIC), which is less biased toward parsimony than the un-
adjusted BIC (Sclove, 1987). This initial factor analysis was 
conducted as a single group analysis with all participants 
included. Potential sex and ethnic differences were then ex-
plored using a multiple-groups model in which item loadings 
and thresholds were estimated freely for each sex and ethnic 
group (e.g., Native American men, White women). A series 
of nested models to determine whether factor loadings and 
thresholds could be constrained across either the two sexes 
or two ethnic groups were then fi t to the data and evaluated 
TABLE 1. Prevalence of cannabis abuse and dependence symptoms in White and Native 
American samples
 Prevalence (%)
Cannabis abuse   Native 
and dependence Full sample Whites Americans
symptoms (n = 1,134) (n = 728) (n = 406) χ2 p
Tolerance 37.4 36.1 39.7 1.39 .2384
Withdrawal* 24.0 21.0 29.1 9.34 .0022
Larger/longer 27.8 26.7 29.8 1.21 .2713
Cut down/control 42.7 41.4 44.8 1.22 .2694
Time spent 44.7 43.7 46.6 0.87 .3510
Reduced activities 27.4 28.0 26.4 0.35 .5541
Caused problems* 47.3 52.6 37.9 22.53 <.0001
Role failure* 36.9 40.1 31.3 8.62 .0033
Hazardous use* 59.3 63.8 51.2 16.91 <.0001
Social problems* 27.5 31.0 21.2 12.55 .0004
*Indicates symptoms that showed signifi cant differences in prevalence across ethnic groups 
(p < .05).
Test of signifi cance
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using a scaled chi-square difference test of log-likelihood 
(LL) values (Satorra and Bentler, 2001) and a comparison of 
SABIC values. Because chi-square difference tests evaluat-
ing model fi t become biased toward more complex models 
as sample sizes increase, a conservative p value of .01 was 
used to determine signifi cance for these analyses.
 After selecting the best-fi tting model, the IRT analysis 
was run and followed up using multiple indicators multiple 
causes (MIMIC) models to test for evidence of DIF. MIMIC 
models can be used to test for DIF in an IRT framework as 
follows: First, a model is run in which the latent response 
factor is regressed on the variable of interest (e.g., sex or 
ethnicity) to measure the direct effect of this variable on 
the latent factor. Second, a path is added to the model in 
which an individual symptom is regressed on the variable 
of interest, providing a measure of the relation between that 
symptom and the variable of interest after accounting for 
its effect on the latent trait. Third, the fi t between a model 
containing this path and a nested model in which this path 
was dropped were compared using the chi-square difference 
test and SABIC as described above.
Results
Symptom prevalence rates
 As seen in Table 1, two of the cannabis-dependence 
symptoms and all three of the assessed abuse symptoms 
showed differences in prevalence across ethnic groups. En-
dorsement of the “withdrawal” symptom was more common 
among Native American than White participants, whereas 
the “caused problems” dependence symptom and the three 
abuse symptoms (“role failure,” “hazardous use,” and “social 
problems”) were less common among Native American than 
White participants.
Factor analysis
 Results of the single group EFA indicated that the 
two-factor solution yielded a better fi t to the data (-2LL = 
-6164.89, BIC = 12441.66) than the single-factor solution 
(-2LL = -6234.37, BIC = 12545.90). Nonetheless, the two 
factors produced by this solution were highly correlated (r 
= .73), and a CFA specifying the two factors as orthogo-
nal yielded a poor fi t to the data (-2LL = -6243.41, BIC 
= 12594.85). Further, an examination of the loadings for 
the single-factor solution showed that all of the symptoms 
showed high loadings with the exception of the “hazardous 
use” and “cut down/control” symptoms (0.54 and 0.49, re-
spectively). Similar results were obtained when the EFA and 
CFA were conducted separately for the White and Native 
American participants. Thus, we concluded that the symptom 
data displayed suffi cient evidence of unidimensionality to 
proceed with the IRT analysis.
Multiple groups analysis
 An initial one-factor model was fi t to the data, allowing 
the item loadings and thresholds to be freely estimated for 
9 of the 10 symptoms for each sex and ethnic group (Table 
2). The factor loading and threshold for the remaining symp-
tom were constrained across groups for model identifi cation 
purposes. A nested model in which factor loadings and 
thresholds were constrained across sex did not result in a 
decline in model fi t, χ2(36) = 58.10, p = .0112, SABIC 
= 15,520.25. A second model suggested that the mean and 
variance of the latent abuse/dependence trait could also 
be constrained across sex, χ2(4) = 6.97, p = .1376, and a 
third model, which was the best-fi tting, suggested that the 
mean and variance of the latent trait could be constrained 
across all groups, χ2(2) = 1.17, p = .5563. Similar analy-
TABLE 2. Results of four-group item response theory analysis
      Sample
 No. of free Log-    size–
Variable parameters likelihood χ2 df p adjusted BIC
Base model 83 -7,639.51 .– . – . .   – 15,599.03
Gender analysis
 Factor loadings and
  thresholds constrained 47 -7,669.52 58.10 36 .0112 15,520.25
 Mean and variance
  constrained across
   gender 43 -7,673.01 6.97 4 .1376 15,511.83
 Mean and variance
  constrained across
   all groups 41 -7,673.67 1.17 2 .5563 15,505.42
Ethnicity analysis
 Factor loadings and
  thresholds constrained 47 -7,711.63 138.58 36 <.0001 15,604.46
 Mean and variance
  constrained 43 -7,716.60 9.85 4 .0430 15,598.98
Notes: Bolded text indicates best-fi tting model. BIC = Bayesian information criterion.
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ses conducted for ethnicity were signifi cant, suggesting that 
the factor loadings and thresholds could not be constrained 
across ethnic groups. Thus, we proceeded to test for DIF as a 
function of ethnicity to identify those symptoms that showed 
differences across the White and Native American samples.
Differential item functioning
 Analyses of ethnic background identifi ed fi ve symptoms 
that yielded signifi cant evidence of DIF (Table 3). The 
withdrawal symptom was shown to be less prevalent among 
Whites than Native Americans, χ2(1) = 24.15, p < .0001, 
suggesting that this symptom indicates increased sever-
ity in Whites. To follow up this result, we compared the 
prevalence rates of the seven items that were used to assess 
for withdrawal (i.e., anxiety/restlessness, sleep problems, 
trembling, sweating, nausea, gastrointestinal distress, and 
appetite changes) across samples. The nausea, χ2(1) = 21.32, 
Fisher’s Exact p < .001, and appetite changes, χ2(1) = 14.98, 
Fisher’s Exact p < .001, items were more prevalent among 
Native Americans and were the only observed signifi cant 
differences. The caused problems, role failure, hazardous 
use, and social problems symptoms were found to be less 
prevalent among Native Americans than Whites, χ2(1) = 
24.48, p < .0001, χ2(1) = 7.81, p = .0052, χ2(1) = 15.73, 
p < .0001, and χ2(1) = 10.36, p = .0013, respectively, thus 
suggesting that these symptoms indicate increased severity 
among Native Americans.
 Two-group IRT models were then run in which either 
the factor loading or threshold of a given symptom was 
constrained across ethnic groups to determine which 
parameter(s) contributed to the presence of DIF for that 
symptom. For all fi ve symptoms, constraining the threshold 
parameter led to a signifi cant decline in model fi t (p values 
< .01) and increases in SABIC values (Table 4). In contrast, 
constraining the factor loadings did not lead to signifi cant 
TABLE 3. Results of multiple indicators multiple causes (MIMIC) model analyses
 Log- Sample size–
Model likelihood adjusted BIC β (SE) χ2a p
Base -6,235.57 12,548.29 .     – .– .   –
Ethnicity as covariate -6,234.66 12,550.34 .     – 1.77 .1830
Tests of DIF
 Tolerance -6,231.50 12,547.88 .40 (.16) 6.46 .0110
 Withdrawal -6,222.60 12,530.07 .88 (.18) 24.15 <.0001
 Larger/longer -6,231.12 12,547.13 .46 (.18) 5.60 .0180
 Cut down/control -6,232.61 12,550.09 .29 (.15) 3.94 .0471
 Time spent -6,232.09 12,549.05 .37 (.16) 5.15 .0232
 Reduced activities -6,234.16 12,553.19 .21 (.22) 0.95 .3297
 Caused problems -6,222.43 12,529.75 -.77 (.16) 24.48 <.0001
 Role failure -6,230.84 12,546.57 -.52 (.19) 7.81 .0052
 Hazardous use -6,226.80 12,538.49 -.56 (.14) 15.73 <.0001
 Social problems -6,229.26 12,543.40 -.62 (.20) 10.36 .0013
Notes: Bolded text indicates signifi cant result at p < .01. BIC = Bayesian information criterion; DIF = 
differential item functioning. aAll chi-square difference tests have 1 df.
TABLE 4. Results of two-group item response theory analysis
 Constrained No. of free Log-    Sample size–
Symptom parameter parameters likelihood χ2 df p adjusted BIC
Base model       – 31 -6,922.92 .– – .   – 13,965.44
Withdrawal Loading 30 -6,923.69 1.60 1 .2060 13,962.13
    Threshold 30 -6,928.01 11.65 1 .0006* 13,968.13
Caused Loading 30 -6,923.63 1.31 1 .2521 13,961.99
 problems Threshold 30 -6,938.48 24.05 1 <.0001* 13,997.66
Role failure Loading 30 -6,923.04 0.20 1 .6578 13,963.86
    Threshold 30 -6,929.87 13.98 1 .0002* 13,979.96
Hazardous Loading 30 -6,926.58 5.65 1 .0174 13,965.06
 use Threshold 30 -6,935.48 26.88 1 <.0001* 13,990.00
Social Loading 30 -6,924.02 2.15 1 .1424 13,962.21




   constrained  26 -6,929.00 11.52 5 .0420 13,958.30
Notes: BIC = Bayesian information criterion; bolded text indicates best-fi tting model.
*Indicates signifi cant result at p < .01.
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declines in model fi t (p values > .01) and led to lower SAB-
IC values. As a fi nal step, a model was evaluated in which 
all factor loadings were constrained across ethnic groups but 
the thresholds were allowed to vary for the fi ve symptoms 
showing evidence of DIF. This fi nal model did not result in 
a decline in model fi t, χ2(5) = 11.52, p = .0420, SABIC = 
13,958.30, suggesting that the more parsimonious model was 
the best-fi tting (see Table 5 for fi nal parameter estimates).
 Notably, all analyses were rerun to evaluate the impact 
of age, sex, and level of education on the study results. 
Inclusion of each variable as a covariate did not lead to any 
changes in the observed pattern of results, suggesting that 
the reported fi ndings were independent of any differences 
between samples on these variables. To control for poten-
tial differences in the severity of use across samples, we 
also evaluated the length of time in years that participants 
reported using cannabis on a daily basis as a covariate. 
Although Native American participants reported greater 
daily use (M = 4.06 years, SD = 5.89, range: 0–40 years) 
than European American participants (M = 3.71 years, SD = 
6.29, range: 0–30 years), this difference was not signifi cant, 
t(1128) = 0.914, p = .361. Further, including this measure 
as a covariate in our analyses resulted in only one change 
in terms of statistical signifi cance of the results. Specifi -
cally, in the two-group IRT models, the threshold for social 
problems could be constrained when years of daily use was 
included as a covariate, but this did not result in a change to 
the best-fi tting model. Thus, for ease of presentation, study 
results were reported without the inclusion of the described 
covariates.
Discussion
 The present study sought (a) to evaluate whether cannabis 
misuse symptoms assess a continuous latent trait that indexes 
the severity of cannabis use in both Native Americans living 
on reservations and European Americans and (b) to evaluate 
whether individual cannabis misuse symptoms differentially 
index severity in these two populations. Study fi ndings sup-
ported previous reports suggesting that cannabis abuse and 
dependence symptoms describe a continuous, unidimen-
sional latent trait indexing the severity of an individual’s 
cannabis use and that these symptoms are interspersed 
along the severity continuum rather than organized into a 
set of mild and severe symptoms as suggested by DSM-IV 
(Agrawal and Lynskey, 2007; Compton et al., 2009; Martin 
et al., 2006). The presence of DIF of cannabis misuse symp-
toms across male and female participants was not directly 
evaluated, but the results of the present study suggested that 
such differences were likely to be limited in scope. This 
is consistent with a previous study that tested for DIF of 
DSM-III-R (American Psychiatric Association, 1987) can-
nabis abuse and dependence symptoms as a function of sex 
in the present Native American sample. This study reported 
signifi cant evidence of DIF as a function of sex for only a 
single symptom (hazardous use) (Gilder et al., 2009), though 
other studies have reported more prominent sex differences 
(Harford et al., 2009; Srisurapanont et al., 2012).
 The present study also demonstrated that cannabis misuse 
symptoms can show important differences in prevalence 
and severity across ethnic groups. Specifi cally, the cannabis 
withdrawal symptom was shown to be more prevalent and 
less severe among Native Americans relative to European 
Americans, whereas the caused problems symptom and the 
three assessed abuse symptoms (role failure, hazardous use, 
and social problems) were shown to be less prevalent and 
more severe among Native Americans relative to European 
Americans. Notably, withdrawal has typically been found to 
be one of the most severe cannabis misuse symptoms in pre-
vious studies (Agrawal and Lynskey, 2007; Gillespie et al., 
2007; Harford et al., 2009; Piontek et al., 2011). Although 
withdrawal represented a relatively severe symptom among 
Native Americans in the present sample, the most severe 
symptom in this group was the social problems abuse symp-
tom, which represents a psychosocial manifestation of the 
disorder rather than a physiological dependence. In addition, 
other psychosocial symptoms (e.g., role failure, hazardous 
use) were found to indicate increased severity relative to 
European Americans.
 These fi ndings have several important implications. First, 
these fi ndings are relevant to theories attempting to explain 
the high rates of cannabis and other drug misuse among Na-
tive Americans living on reservations. Among these theories, 
some researchers have suggested that the increased rates of 
drug dependence within this population can be attributed 
to early exposure (Ehlers et al., 2007) and a lack of contin-
gency between access to basic life reinforcers (e.g., employ-
ment, education, housing) and sobriety (Spillane and Smith, 
2007). The reported result that the socially contingent abuse 
symptoms represent more severe symptoms among Native 
Americans than European Americans suggests that social 
contingencies are more frequently violated in the presence of 
TABLE 5. Item response theory parameters from two-group analysis with 
all factor loadings, means, and variances and selected thresholds constrained 
across ethnicity
Cannabis abuse
and dependence  European Native
symptoms Discrimination (SE) Americans Americans
Tolerance 0.86 (0.08) 0.49 (0.06) 0.49 (0.06)
Withdrawala 0.95 (0.09) 0.82 (0.10) 1.18 (0.10)
Larger/longer 0.98 (0.09) 0.84 (0.07) 0.84 (0.07)
Cut down/control 0.64 (0.06) 0.34 (0.07) 0.34 (0.07)
Time spent 0.97 (0.08) 0.19 (0.05) 0.19 (0.05)
Reduced activities 1.48 (0.15) 0.74 (0.06) 0.74 (0.06)
Caused problemsa 0.86 (0.08) 0.50 (0.09) -0.13 (0.07)
Role failurea 1.32 (0.13) 0.64 (0.08) 0.30 (0.06)
Hazardous usea 0.56 (0.06) -0.02 (0.12) -0.72 (0.11)
Social problemsa 1.11 (0.10) 1.09 (0.10) 0.66 (0.07)
aIndicates that threshold was allowed to vary across ethnic groups.
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heavy cannabis use among European Americans and less so 
among Native Americans living on reservations. This would 
appear to support theories suggesting a lack of contingency 
between social and occupational obligations and sobriety. 
Prospective, longitudinal studies are needed to formally 
evaluate these conclusions, but the present study provides a 
preliminary examination of differences in the presentation 
of cannabis abuse dependence among Native Americans and 
European Americans.
 Second, evidence of DIF for a specifi c symptom suggests 
limitations of that symptom in assessing the disorder of 
interest. For example, if the abuse symptoms are culturally 
infl uenced as indicated by the present study, this would sug-
gest a limitation of those symptoms in assessing substance 
misuse across cultures. Similarly, if symptoms such as with-
drawal show evidence of DIF, it could indicate a weakness in 
how that symptom is operationalized. A cannabis withdrawal 
syndrome has only recently been described in the literature, 
and thus items assessing this syndrome may require further 
refi nement. Symptoms most frequently associated with can-
nabis withdrawal include anxiety, decreased appetite/weight 
loss, irritability, restlessness, sleep problems, and strange 
dreams, whereas physical symptoms such as nausea, sweat-
ing, vomiting, and diarrhea have not been consistently asso-
ciated with cannabis withdrawal (Budney et al., 2004). The 
present study found that withdrawal symptoms of nausea and 
appetite changes were more prevalent among Native Ameri-
can participants and thus were likely responsible for the 
presence of DIF for the withdrawal symptom. It is possible 
that genetically infl uenced differences in the metabolism of 
the active substances found in cannabis led to the differences 
in prevalence rates, or there may be differences in how these 
items are interpreted across groups that give rise to the dif-
ferences. Further studies will be needed to evaluate these 
possibilities, but in either case, these fi ndings demonstrate 
the importance of studying substance use disorders across 
ethnic and cultural groups for the purpose of refi ning diag-
nostic assessment.
 Third, these fi ndings also have important implications 
for psychological research and practice regarding substance 
use disorders more generally. There is a growing emphasis 
on conducting large-scale, collaborative research, often 
across diverse cultural groups; thus, there is a need for data 
harmonization methods to ensure that the data collected 
can be equated across groups (Granda and Blasczyk, 2010; 
Hamilton et al., 2011; Khoury et al., 2004). The reported 
fi ndings provide one method for investigating potential 
cultural differences in the process of data harmonization. 
In fact, the present report represents an initial step in 
harmonizing substance misuse data for use in genomic 
sequencing studies currently being conducted in the de-
scribed populations. The reported fi ndings also suggest that 
assessment, prevention, and treatment efforts for cannabis 
use disorders should consider cultural differences in symp-
tom presentation. For example, if specifi c cannabis misuse 
symptoms manifest at different points in the course of the 
disorder among Native Americans and Whites, prevention 
efforts focusing on identifying early signs of problematic 
use or treatments designed to curtail use may need to be 
tailored to each population.
 Although the fi ndings described in the present report have 
the potential to further our understanding of the etiology of 
cannabis abuse and dependence, there are some limitations. 
Whereas the cannabis abuse and dependence symptoms 
assessed in the present study are largely consistent with 
those presented in the DSM-IV, the noted differences (i.e., 
“caused problems” rather than “continued use despite expe-
riencing problems” and the absence of the legal problems 
abuse symptom) limit the extent to which we can apply 
these fi ndings to the complete DSM-IV cannabis abuse and 
dependence symptoms. Nonetheless, the reported results 
provide important insights into differences in the develop-
ment of these disorders between Native Americans and 
European Americans. It should also be noted that different 
ascertainment procedures were used to collect each sample, 
which raise potential questions about their comparability. A 
series of covariates including age, gender, level of educa-
tion, and severity of use was used to evaluate this possibility, 
and study fi ndings suggested that the reported differences 
between Native Americans and European Americans were 
robust to sample differences across these variables. Future 
studies using more uniform ascertainment procedures across 
ethnic groups would provide a strong test of the replicability 
of the reported fi ndings. Finally, the Native Americans as-
sessed in the present study represent individuals living on a 
set of contiguous reservations. Further studies are needed to 
determine whether these fi ndings can be extended to other 
Native American populations.
 In summary, the present report found that the prevalence 
and severity of cannabis abuse and dependence symptoms 
differ between Native Americans and European Americans. 
Specifi cally, withdrawal symptoms indicating a physiologi-
cal dependence are less prevalent and indicate a more severe 
form of cannabis misuse in European Americans compared 
with Native Americans. In contrast, socially contingent 
symptoms indicating a failure to meet role obligations and 
social diffi culties resulting from cannabis use are less preva-
lent and indicate a more severe form of cannabis misuse 
among Native Americans compared with European Ameri-
cans. These fi ndings describe potential cultural differences in 
the manifestation of cannabis misuse symptoms and have the 
potential to inform the research, assessment, and treatment 
of cannabis misuse disorders in these populations.
Acknowledgment
 The authors thank Derek Wills for his assistance in data management 
and analysis.
 GIZER ET AL. 327
References
Agrawal, A., & Lynskey, M. T. (2007). Does gender contribute to heteroge-
neity in criteria for cannabis abuse and dependence? Results from the 
National Epidemiological Survey on Alcohol and Related Conditions. 
Drug and Alcohol Dependence, 88, 300–307.
American Psychiatric Association. (1987). Diagnostic and statistical manual 
of mental disorders (3rd ed., rev.). Washington, DC: Author.
American Psychiatric Association. (1994). Diagnostic and statistical manual 
of mental disorders (4th ed.). Washington, DC: Author.
Anthony, J. C., Warner, L. A., & Kessler, R. C. (1994). Comparative epi-
demiology of dependence on tobacco, alcohol, controlled substances, 
and inhalants: Basic fi ndings from the National Comorbidity Survey. 
Experimental and Clinical Psychopharmacology, 2, 244–268.
Beauvais, F. (1992). Trends in Indian adolescent drug and alcohol use. 
American Indian and Alaska Native Mental Health Research, 5, 1–12.
Bucholz, K. K., Cadoret, R., Cloninger, C. R., Dinwiddie, S. H., Hessel-
brock, V. M., Nurnberger, J. I., Jr., . . . Schuckit, M. A. (1994). A new, 
semi-structured psychiatric interview for use in genetic linkage studies: 
A report on the reliability of the SSAGA. Journal of Studies on Alcohol, 
55, 149–158.
Budney, A. J., Hughes, J. R., Moore, B. A., & Vandrey, R. (2004). Review of 
the validity and signifi cance of cannabis withdrawal syndrome. Ameri-
can Journal of Psychiatry, 161, 1967–1977.
Compton, W. M., Grant, B. F., Colliver, J. D., Glantz, M. D., & Stinson, F. 
S. (2004). Prevalence of marijuana use disorders in the United States: 
1991-1992 and 2001-2002. Journal of the American Medical Associa-
tion, 291, 2114–2121.
Compton, W. M., Saha, T. D., Conway, K. P., & Grant, B. F. (2009). The 
role of cannabis use within a dimensional approach to cannabis use 
disorders. Drug and Alcohol Dependence, 100, 221–227.
Degenhardt, L., Hall, W., & Lynskey, M. (2003). Exploring the association 
between cannabis use and depression. Addiction, 98, 1493–1504.
Ehlers, C. L., Gilder, D. A., & Phillips, E. (2008). P3 components of the 
event-related potential and marijuana dependence in Southwest Califor-
nia Indians. Addiction Biology, 13, 130–142.
Ehlers, C. L., Gizer, I. R., Vieten, C., Gilder, D. A., Stouffer, G. M., Lau, P., 
& Wilhelmsen, K. C. (2010). Cannabis dependence in the San Francisco 
Family Study: Age of onset of use, DSM-IV symptoms, withdrawal, and 
heritability. Addictive Behaviors, 35, 102–110.
Ehlers, C. L., Wall, T. L., Betancourt, M., & Gilder, D. A. (2004). The clini-
cal course of alcoholism in 243 Mission Indians. American Journal of 
Psychiatry, 161, 1204–1210.
Ehlers, C. L., Wall, T. L., Corey, L., Lau, P., Gilder, D. A., & Wilhelmsen, 
K. C. (2007). Heritability of illicit drug use and transition to dependence 
in Southwest California Indians. Psychiatric Genetics, 17, 171–176.
Ehlers, C. L., Wall, T. L., Garcia-Andrade, C., & Phillips, E. (2001). EEG 
asymmetry: Relationship to mood and risk for alcoholism in Mission 
Indian youth. Biological Psychiatry, 50, 129–136.
Embretson, S. E., & Reise, S. P. (2000). Item response theory for psycholo-
gists. Mahwah, NJ: Lawrence Erlbaum.
Fergusson, D. M., & Horwood, L. J. (2000). Does cannabis use encourage 
other forms of illicit drug use? Addiction, 95, 505–520.
Gilder, D. A., Lau, P., & Ehlers, C. L. (2009). Item response theory analysis 
of lifetime cannabis-use disorder symptom severity in an American 
Indian community sample. Journal of Studies on Alcohol and Drugs, 
70, 839–849.
Gilder, D. A., Wall, T. L., & Ehlers, C. L. (2004). Comorbidity of select 
anxiety and affective disorders with alcohol dependence in southwest 
California Indians. Alcoholism: Clinical and Experimental Research, 
28, 1805–1813.
Gillespie, N. A., Neale, M. C., Prescott, C. A., Aggen, S. H., & Kendler, 
K. S. (2007). Factor and item-response analysis DSM-IV criteria for 
abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, 
stimulants and opioids. Addiction, 102, 920–930.
Granda, P., & Blasczyk, E. (2010). Data harmonization: Guidelines for 
best practice in cross-cultural surveys. Ann Arbor, MI: Survey Research 
Centre, Institute for Social Research, University of Michigan.
Grant, B. F., Dawson, D. A., Stinson, F. S., Chou, S. P., Dufour, M. C., & 
Pickering, R. P. (2004). The 12-month prevalence and trends in DSM-IV 
alcohol abuse and dependence: United States, 1991-1992 and 2001-
2002. Drug and Alcohol Dependence, 74, 223–234.
Hall, W., Degenhardt, L., & Teesson, M. (2004). Cannabis use and psychotic 
disorders: An update. Drug and Alcohol Review, 23, 433–443.
Hamilton, C. M., Strader, L. C., Pratt, J. G., Maiese, D., Hendershot, T., 
Kwok, R. K., . . . Haines, J. (2011). The PhenX Toolkit: Get the most 
from your measures. American Journal of Epidemiology, 174, 253–260.
Harford, T. C., Yi, H. Y., Faden, V. B., & Chen, C. M. (2009). The dimen-
sionality of DSM-IV alcohol use disorders among adolescent and adult 
drinkers and symptom patterns by age, gender, and race/ethnicity. Alco-
holism: Clinical and Experimental Research, 33, 868–878.
Heckathorn, D. D. (1997). Respondent-driven sampling: A new approach to 
the study of hidden populations. Social Problems, 44, 174–199.
Helzer, J. E., Bucholz, K. K., & Gossop, M. (2007). A dimensional op-
tion for the diagnosis of substance dependence in DSM-V. Interna-
tional Journal of Methods in Psychiatric Research, 16, Supplement 1, 
S24–S33.
Kalton, G., & Anderson, D. W. (1986). Sampling rare populations. Journal 
of the Royal Statistical Society. Series A (General), 149, 65–82.
Khoury, M. J., Millikan, R., Little, J., & Gwinn, M. (2004). The emergence 
of epidemiology in the genomics age. International Journal of Epide-
miology, 33, 936–944.
Lynskey, M. T., Heath, A. C., Bucholz, K. K., Slutske, W. S., Madden, P. A. 
F., Nelson, E. C., . . . Martin, N. G. (2003). Escalation of drug use in 
early-onset cannabis users vs co-twin controls. Journal of the American 
Medical Association, 289, 427–433.
Martin, C. S., Chung, T., Kirisci, L., & Langenbucher, J. W. (2006). Item 
response theory analysis of diagnostic criteria for alcohol and cannabis 
use disorders in adolescents: Implications for DSM-V. Journal of Ab-
normal Psychology, 115, 807–814.
Muhib, F. B., Lin, L. S., Stueve, A., Miller, R. L., Ford, W. L., Johnson, W. 
D., & Smith, P. J., & the Community Intervention Trial for Youth Study 
Team. (2001). A venue-based method for sampling hard-to-reach popu-
lations. Public Health Reports, 116, Supplement 1, 216–222.
Muthén, B., & Muthén, L. (2010). Mplus user’s guide (6th ed.). Los Ange-
les, CA: Authors.
O’Brien, C. (2011). Addiction and dependence in DSM-V. Addiction, 106, 
866–867.
Piontek, D., Kraus, L., Legleye, S., & Bühringer, G. (2011). The validity of 
DSM-IV cannabis abuse and dependence criteria in adolescents and the 
value of additional cannabis use indicators. Addiction, 106, 1137–1145.
Plunkett, M., & Mitchell, C. M. (2000). Substance use rates among Ameri-
can Indian adolescents: Regional comparisons with monitoring the 
future high school seniors. Journal of Drug Issues, 30, 575–591.
Pope, H. G., Jr., Gruber, A. J., Hudson, J. I., Huestis, M. A., & Yurgelun-
Todd, D. (2001). Neuropsychological performance in long-term cannabis 
users. Archives of General Psychiatry, 58, 909–915.
Saha, T. D., Chou, S. P., & Grant, B. F. (2006). Toward an alcohol use dis-
order continuum using item response theory: Results from the National 
Epidemiologic Survey on Alcohol and Related Conditions. Psychologi-
cal Medicine, 36, 931–941.
Satorra, A., & Bentler, P. M. (2001). A scaled difference chi-square test 
statistic for moment structure analysis. Psychometrika, 66, 507–514.
Schuckit, M. (2006). Drug and alcohol abuse (6th ed.). New York, NY: 
Springer.
Sclove, L. S. (1987). Application of model-selection criteria to some prob-
lems in multivariate analysis. Psychometrika, 52, 333–343.
328 JOURNAL OF STUDIES ON ALCOHOL AND DRUGS / MARCH 2013
Sharma, B. P. (1975). Cannabis and its users in Nepal. British Journal of 
Psychiatry, 127, 550–552.
Solowij, N., Stephens, R. S., Roffman, R. A., Babor, T., Kadden, R., Miller, 
M., . . . Vendetti, J. & the Marijuana Treatment Project Research Group. 
(2002). Cognitive functioning of long-term heavy cannabis users seeking 
treatment. Journal of the American Medical Association, 287, 1123–1131.
Spillane, N. S., & Smith, G. T. (2007). A theory of reservation-dwelling 
American Indian alcohol use risk. Psychological Bulletin, 133, 395–418.
Srisurapanont, M., Kittiratanapaiboon, P., Likhitsathian, S., Kongsuk, T., 
Suttajit, S., & Junsirimongkol, B. (2012). Patterns of alcohol depen-
dence in Thai drinkers: A differential item functioning analysis of 
gender and age bias. Addictive Behaviors, 37, 173–178.
Stinson, F. S., Ruan, W. J., Pickering, R., & Grant, B. F. (2006). Cannabis 
use disorders in the USA: Prevalence, correlates and co-morbidity. 
Psychological Medicine, 36, 1447–1460.
Substance Abuse and Mental Health Services Administration. (2011). 
Results from the 2010 National Survey on Drug Use and Health: Sum-
mary of National Findings. Retrieved from www.samhsa.gov/data/
NSDUH/2k10NSDUH/2k10Results.pdf
Wu, L.-T., Pan, J.-J., Blazer, D. G., Tai, B., Stitzer, M. L., Brooner, R. K., 
. . . Blaine, J. D. (2009). An item response theory modeling of alcohol 
and marijuana dependences: A National Drug Abuse Treatment Clini-
cal Trials Network study. Journal of Studies on Alcohol and Drugs, 70, 
414–425.
